SA PRO
Free Account
Terns Pharmaceuticals, Inc.TERNNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 93% recommend buying.

Consensus Rating
Buy
15 analysts·Moderate coverage
93%
Rating Distribution
Strong Buy
00%
Buy
1493%
Hold
17%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 44% higher.

Bear Case
$35.00
-9%
Consensus
$55.38
+44%
Bull Case
$70.00
+82%
Price Range15 analysts
Low
Consensus
High
$35.00
$70.00
Current Target
Current Price
$38.52
Upside to Target
$16.86

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.18(7 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+440.62%
EPS—
FY2028
Rev+36.99%
EPS—
FY2029
Rev+814.02%
EPS—

Earnings Surprises

Beat rate:75%(9/12 quarters)
Avg surprise:+8.1%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 10, 2025Jefferies
Terns Pharmaceuticals (TERN) PT Raised to $70 at Jefferies
Target:$70.00
+56.2%from $44.83
Dec 9, 2025Oppenheimer
Terns Pharmaceuticals price target raised to $58 from $28 at Oppenheimer
Target:$58.00
+37.4%from $42.22
Dec 9, 2025BMO Capital
Terns Pharmaceuticals price target raised to $54 from $35 at BMO Capital
Target:$54.00
+34.2%from $40.23
Dec 9, 2025Truist Financial
Terns Pharmaceuticals price target raised to $56 from $35 at Truist
Target:$56.00
+39.2%from $40.23
Dec 9, 2025Mizuho Securities
Terns Pharmaceuticals price target raised to $54 from $33 at Mizuho
Target:$54.00
+34.2%from $40.23
Dec 9, 2025H.C. Wainwright
Terns Pharmaceuticals price target raised to $60 from $20 at H.C. Wainwright
Target:$60.00
+49.1%from $40.23
Dec 9, 2025Barclays
Terns Pharmaceuticals price target raised to $56 from $36 at Barclays
Target:$56.00
+39.2%from $40.23
Nov 28, 2025Mizuho Securities
Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Target:$33.00
+14.8%from $28.75
Nov 26, 2025JMP Securities
Terns Pharmaceuticals price target raised to $35 from $25 at Citizens JMP
Target:$35.00
+24.3%from $28.16
Nov 25, 2025Barclays
Terns Pharmaceuticals price target raised to $36 from $28 at Barclays
Target:$36.00
+28.4%from $28.04
Nov 18, 2025BMO Capital
Terns Pharmaceuticals price target raised to $30 from $22 at BMO Capital
Target:$30.00
+8.9%from $27.56
Nov 11, 2025Barclays
Terns Pharmaceuticals price target raised to $28 from $27 at Barclays
Target:$28.00
+46.4%from $19.12
Nov 4, 2025H.C. Wainwright
H.C. Wainwright upgrades Terns on 'compelling' TERN-701 data
Target:$20.00
+42.6%from $14.03
Nov 4, 2025Truist Financial
Terns Pharmaceuticals (TERN) PT Raised to $28 at Truist Securities
Target:$28.00
+99.6%from $14.03
Nov 4, 2025Barclays
Terns Pharmaceuticals price target raised to $27 from $14 at Barclays
Target:$27.00
+92.4%from $14.03
Nov 3, 2025BMO Capital
Terns Pharmaceuticals price target raised to $22 from $15 at BMO Capital
Target:$22.00
+56.8%from $14.03
Nov 3, 2025Oppenheimer
Terns Pharmaceuticals (TERN) PT Raised to $24 at Oppenheimer
Target:$24.00
+71.1%from $14.03
Nov 3, 2025Jefferies
Terns Pharmaceuticals price target raised to $35 from $28 at Jefferies
Target:$35.00
+149.5%from $14.03
Oct 23, 2025JMP Securities
Terns Pharmaceuticals price target lowered to $15 from $20 at Citizens JMP
Target:$15.00
+80.8%from $8.29
Oct 22, 2025Mizuho Securities
Terns Pharmaceuticals price target lowered to $9 from $14 at Mizuho
Target:$9.00
+10.8%from $8.12
Oct 22, 2025Oppenheimer
Terns Pharmaceuticals price target lowered to $17 from $20 at Oppenheimer
Target:$17.00
+109.4%from $8.12
Oct 22, 2025Barclays
Terns Pharmaceuticals price target lowered to $14 from $15 at Barclays
Target:$14.00
+85.9%from $7.53
Oct 14, 2025Truist Financial
Terns Pharmaceuticals initiated with a Buy at Truist
Target:$20.00
+147.5%from $8.08
Sep 16, 2025Barclays
Terns Pharmaceuticals initiated with an Overweight at Barclays
Target:$15.00
+105.5%from $7.30
Dec 3, 2024Oppenheimer
Terns Pharmaceuticals (TERN) PT Raised to $20 at Oppenheimer
Target:$20.00
+214.5%from $6.36

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance